Dapsone Gel
Product Images NDC 62332-551

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 62332-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D9849120 Ccaa 4820 8e8d 3a8c7d809ffb 01)

Chemical structure of dapsone showing two benzene rings connected by a sulfone (SO2) group, each benzene ring with an amine (NH2) substituent.*

FDA Label Image

60 G Tube Label (D9849120 Ccaa 4820 8e8d 3a8c7d809ffb 02)

Label for Dapsone Gel 5% topical gel, 60 g, by Alembic Pharmaceuticals Inc. The label includes usage instructions, storage guidelines, and manufacturer details. It states the gel contains 50 mg dapsone per gram and is for topical use only, not for oral, ophthalmic, or intravaginal use.*

FDA Label Image

60 G Carton Label (D9849120 Ccaa 4820 8e8d 3a8c7d809ffb 03)

Dapsone Gel 5% topical gel packaging label for a 60 g tube. The label states it is for topical use only, not for oral, ophthalmic, or intravaginal use. The product is Rx only and manufactured by Alembic Pharmaceuticals Inc. The label includes warnings, storage instructions, and manufacturing details for Alembic Pharmaceuticals Limited, India. The NDC is 62332-551-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.